HAMAM

Despite tremendous advances in modern imaging technology, both early detection and accurate diagnosis of breast cancer are still unresolved challenges. Today, a variety of imaging modalities and image-guided biopsy procedures exist to identify and characterize morphology and function of suspicious breast tissue. However, a clinically feasible solution for breast imaging, which is both highly sensitive and specific with respect to breast cancer, is still missing. As a consequence, unnecessary biopsies are taken and tumours frequently go undetected until a stage where therapy is costly or unsuccessful.

HAMAM (Highly accurate breast cancer diagnosis through integration of biological knowledge, novel imaging modalities, and modelling) project will tackle this challenge by providing a means to seamlessly integrate the available multi-modal images and the patient information on a single clinical workstation. Based on knowledge gained from a large multi-disciplinary database, populated within the scope of this project, suspicious breast tissue will be characterised and classified.

HAMAM will achieve this by:

  • Building the tools needed to integrate datasets / modalities into a single interface.
  • Providing pre processing / standardization tools that will allow for optimal comparison of disparate data
  • Building spatial correlation information datasets to allow for new similarity and multimodal tissue models. These will be key in the detection and diagnosis of breast cancer
  • Building in adaptability that allows for the integration of other sources of knowledge such as tumour models, genetic data, genotype, phenotype and standardised imaging.

The exact diagnosis of suspicious breast tissue is ambiguous in many cases. HAMAM will resolve this using the statistical knowledge extracted from the large case database. The clinical workstation will suggest additional image modalities that may be captured to optimally resolve these uncertainties. The workstation thus guides the clinician in establishing a patient specific optimal diagnosis. This ultimately leads to a more specific and individual diagnosis.

For further information, please visit:
http://www.hamam-project.eu

Project co-ordinator:
EIBIR gemeinnuetzige GmbH zur Foerderung der. Erforschung der biomedizinischen Bildgebung

Partners:

  • Boca Raton Community Hospital Inc (USA)
  • MeVis Research GmbH (Germany)
  • MeVis Medical Solutions AG (Germany)
  • University College London (United Kingdom)
  • Radboud Universiteit Nijmegen - Stichting Katholieke Universiteit (Netherlands)
  • Charité - Universitätsmedizin Berlin (Germany)
  • The University of Dundee (United Kingdom)
  • Eidgenössische Technische Hochschule Zürich (Switzerland)

Timetable: from 09/2008 - to 08/2011

Total cost: € 4.250.000

EC funding: € 3.100.000

Programme Acronym: FP7-ICT

Subprogramme Area: Virtual physiological human

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Virtual Humans Help Aspiring Doctors Lea…

For medical student Katie Goldrath, the first time delivering difficult health news came when she had to tell a young woman named Robin and her mom, Delmy, that Robin had...

Read more

'Smart Contact Lens Sensor' for Diabetic…

A recent study, affiliated with Ulsan National Institute of Science and Technology (UNIST), South Korea, has proposed the possibility of in situ human health monitoring simply by wearing a contact...

Read more

2017 eHealth Competition Awards SilverCl…

The eHealth Competition is an initiative that rewards the best digital health solutions produced by SMEs across Europe. This edition has been supported by Astrazeneca, Ship2B and Younoodle. This competition...

Read more

ECDC Report Shows Strong Potential of E-…

Twenty one EU/EEA countries have developed or are in the process of developing systems to digitally record information about vaccination, according to a new "ECDC survey report on immunisation information...

Read more

Devicare Raises 3 Million Euros in its C…

Devicare, a company specializing in innovative medical devices for chronic home care patients under Remote Patient Monitoring (RPM), has closed out a seed round of 3 million euros. This funding...

Read more

Successful Conclusion to conhIT 2017, th…

25 - 27 April 2017, Berlin, Germany. As conhIT, which took place from 25 to 27 April in Berlin, came to a close, 500 exhibitors, 9,500 participants from around the world...

Read more

Compiling Big Data in a Human-Centric Wa…

When a group of researchers in the Undiagnosed Disease Network at Baylor College of Medicine realized they were spending days combing through databases searching for information regarding gene variants, they...

Read more

Scopis Introduces the First Mixed-Realit…

Scopis, a company specializing in surgical navigation and medical augmented and mixed reality technologies, announced today the launch of its newest development, the Holographic Navigation Platform for use in surgery...

Read more

IMS MAXIMS Launches Vital Signs Mobile A…

Clinical technology specialist IMS MAXIMS will be launching its fully integrated vital signs application at eHealth Week on 3rd and 4th May in Olympia, London. Delegates will be the first...

Read more

Immunisation Information Systems in the …

Immunisation information systems (IIS) are defined as confidential, population-based, computerised databases that record all immunisation doses administered by participating providers to persons residing within a given geopolitical area. At the...

Read more

Abbott Announces CE Mark and First Use o…

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify...

Read more

Using a Smartphone to Screen for Male In…

More than 45 million couples worldwide grapple with infertility, but current standard methods for diagnosing male infertility can be expensive, labor-intensive and require testing in a clinical setting. Cultural and...

Read more